INTRODUCTION
It is known that in patients with chronic obstructive pulmonary disease (COPD), right heart function is impaired (6) and severity of pulmonary hypertension (PH) relates to prognosis (13) . Long-term oxygen therapy (14) and potentiating medication (5) may improve the prognosis by reducing pulmonary hypertension. This determines the necessity for noninvasive evaluation of pulmonary hypertension (1) and associated disorders in right ventricular (RV) function. The non-invasive estimation of pulmonary artery (PA) pressures is accompanied by a series of
MATERIAL AND METHODS
In the present study, inclusion criteria were history of bronchitis, emphysema on x-ray, physical findings of crackles and wheezing, acidbase status and spirometry (4) . Exclusion criteria were hypertension, myocardial infarction, angina pectoris, acquired and congenital cardiac defects. Hypertension was allowed in the group of patients with COPD and atrial fibrillation (AF).
Using two-dimensional and M-mode subxiphoid echocardiography, the following parameters were studied in 75 COPD patients: dimensions of inferior vena cava (IVC) and percentage of inspiratory collapse-inspiratory collapsibility index (ICI ), enddiastolic thickness of the right ventricular wall (EDRVWT) by two-dimensional directed M-mode echocardiography, end-diastolic inflow diameter of the right ventricle (RV) at the level of the tricuspid valve (EDDRV), right atrial area (RAA) and RV end-systolic and end-diastolic areas (ESRVA and EDRVAd), and RV area (RVA) change. All the indices were corrected for body surface area (BSA) ( Table 1) .
After exclusion of AF patients, COPD ones in sinus rhythm were divided in three ways depending on: i) the presence or absence of pulmonary hypertension and/or RV hypertrophy by x-ray criteria or ECG (8, 16) ;
ii) right heart failure of NYHA I-II class, i.e. no episodes of peripheral edema and NYHA III-IV class with one or more episodes of peripheral edema, and iii) the severity of respiratory failure of grade 0-I with or without hypoxemia at rest, of grade II with presence of hypercapnia, and of grade III with persistent decompensated acidosis despite 7-14 days of standard hospital treatment.
Results were compared to those of 30 healthy subjects. ANOVA and statistical indices such as sensitivity, specificity and predictive accuracy were used ( Table 2) .
RESULTS
Subxiphoid approach proved successful for visualization of IVC in 95%, -for EDRVWT measurement in 87% and for two-dimensional echocardiography measurements in 69% of the cases.
Demographic and respiratory status of the patients and controls was shown on Table 3 . Any ultrasound parameters in COPD patients were significantly changed compared to healthy controls. The same was true for COPD patients with AF whose indices were equally changed from the control group and did not differ from the patients in sinus rhythm. The parameters of the patients without PH were also statistically significantly different from those of healthy controls except for IVC and RV area fractional shortening. The characteristics of these patients differed from those of the patients with PH except RVA fractional shortening (RVAFS), too. Statistically significant changes were found out for any parameters with advancement of cardiac and respiratory failure. During the two-year study period, seven (9%) patients died in end stage respiratory and heart failure because of considerably reduced right heart performance ( Table 4 and Table 5) . Normal values of various echocardiographic indices were estimated and upper normal reference limits were used for calculating the sensitivity and specificity. Using normal reference limits from healthy volunteers, at least 50% of COPD patients without PH presented with altered parameters, including the patients with no hypoxemia at rest. At specificity and predictive accuracy of 100%, sensitivity for PH group varied from 71% to 93% for various echocardiographic parameters, the highest being for EDRVWT and IVC/IC. RVAFS was characterized by exceptionally low sensitivity in all the groups (Table 6 ).
DISCUSSION
Right-heart echocardiagraphic subxiphoid parameters distinguish highly significantly the healthy subjects from COPD patients and this has already been observed in several studies of lung diseases, too. Subxiphoid echocardiography correlates both with radionuclide angiography and magnetic resonance imaging (10, 11) .
Doppler studies, on the other hand, are deemed suitable for screening purposes, however, they lack accuracy (12) . Doppler method of formula estimation of PA pressure using the velocity of tricuspid regurgitation in pulmonary diseases is considered the most convenient one (3). 11,3±2,9 (7, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) 8) 13,5±5,1 (6, (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) 1) 9,6±3,61 (4, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) 3) 28,9±3,6 (22-33) Table 5 . Echocardiographic results in COPD patients according to cardiac and respiratory status * -p < 0,001; -p < 0,01; -p < 0,02; ∆ -p < 0,05; NS -not significant Controlled AF does not change statistically these parameters in comparison with PH patients. Evolution of chronic cardiac and respiratory failure significantly worsens all the parameters of right heart function. Normal values of subxiphoid echocardiographic indices of the group of healthy volunteers correspond to those reported in the literature available. At 100% specificity, all the indicators possess high sensitivity in PH patients with highest EDRVWT and IVC/IC rates. This can be used for early diagnosis of cor pulmonale in chronic respiratory disease. Subxiphoid echocardiography enables an improved recognition of cor pulmonale in severe COPD (7) .
Echocardiographic examination has the potential to distinguish patients with and without PH on x-ray and RV hypertrophy on ECG. These indices possess certain predictive value in COPD patients and worsen with advancement of cardiac functional class and severity of respiratory failure. COPD patient's survival is shortened above certain levels of deterioration of right heart function evaluated by echocardiography.
CONCLUSIONS
1. Subxiphoid M-mode and two-dimensional echocardiographic parameters in noncatheterized COPD patients separate them quite accurately from healthy subjects in everyday clinical practice. 2. IVC diameter, its inspiratory collapse and RVWT are of highest sensitivity, specificity and predictive accuracy for early diagnosis of cor pulmonale. 3. The presence of RVH/PH (on ECG and xray), hypercapnia and overt cardiac failure significantly change any echocardiographic parameters from the subxiphoid view. 4. These parameters are changed in at least 50% of COPD patients without RVH/PH studied by both M-mode and two-dimensional echocardiography as IVCD/CI is most sensitive. 5. RVAFS is the least sensitive parameter. 6. Controlled AF in COPD patients seems not to change adversely right heart indexes. 
